Lyra Therapeutics (LYRA) Financial Statements
Price: $0.0991
Market Cap: $6.53M
Avg Volume: 1.17M
Market Cap: $6.53M
Avg Volume: 1.17M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Lyra Therapeutics.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.53M | $1.56M | $1.36M | $285.00K | $- | $- | $1.24M |
| Cost of Revenue | $- | $- | $1.07M | $1.00M | $95.00K | $27.00K | $- |
| Gross Profit | $1.53M | $1.56M | $296.00K | $-716.00K | $-95.00K | $-27.00K | $1.24M |
| Gross Profit Ratio | 100.00% | 100.00% | 21.72% | -251.23% | - | - | 100.00% |
| Research and Development Expenses | $43.77M | $48.03M | $38.80M | $29.69M | $12.52M | $12.03M | $4.97M |
| General and Administrative Expenses | $18.50M | $19.06M | $17.56M | $14.21M | $9.69M | $4.49M | $3.53M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $18.50M | $19.06M | $17.56M | $14.21M | $9.69M | $4.49M | $3.53M |
| Other Expenses | $35.62M | $- | $1.32M | $- | $- | $- | $1.19M |
| Operating Expenses | $97.88M | $68.68M | $56.35M | $43.90M | $22.21M | $16.52M | $8.50M |
| Cost and Expenses | $97.88M | $68.68M | $56.35M | $43.90M | $22.21M | $16.52M | $8.50M |
| Interest Income | $2.95M | $4.50M | $1.04M | $102.00K | $82.00K | $213.00K | $- |
| Interest Expense | $- | $- | $524.00K | $- | $- | $- | $- |
| Depreciation and Amortization | $471.00K | $278.00K | $1.07M | $1.00M | $95.00K | $27.00K | $82.00K |
| EBITDA | $-60.26M | $-65.25M | $-53.92M | $-42.61M | $-22.11M | $-16.49M | $-7.18M |
| EBITDA Ratio | -3928.42% | -4188.06% | -3956.20% | -14952.28% | - | - | -576.93% |
| Operating Income | $-96.35M | $-67.12M | $-56.31M | $-43.62M | $-22.21M | $-16.52M | $-7.26M |
| Operating Income Ratio | -6280.83% | -4308.09% | -4131.03% | -15303.51% | - | - | -583.52% |
| Total Other Income Expenses Net | $2.95M | $4.50M | $1.04M | $102.00K | $82.00K | $213.00K | $1.23M |
| Income Before Tax | $-93.40M | $-62.62M | $-55.27M | $-43.51M | $-22.13M | $-16.31M | $-6.03M |
| Income Before Tax Ratio | -6088.40% | -4019.32% | -4054.66% | -15267.72% | - | - | -484.65% |
| Income Tax Expense | $39.00K | $59.00K | $13.00K | $-1.10M | $-82.00K | $-213.00K | $-1.23M |
| Net Income | $-93.44M | $-62.68M | $-55.28M | $-42.41M | $-22.05M | $-16.09M | $-6.03M |
| Net Income Ratio | -6090.94% | -4023.11% | -4055.61% | -14880.70% | - | - | -484.65% |
| EPS | $-1.43 | $-1.26 | $-1.83 | $-3.27 | $-2.57 | $-1.25 | $-0.96 |
| EPS Diluted | $-1.43 | $-1.26 | $-1.83 | $-3.27 | $-2.57 | $-1.25 | $-0.96 |
| Weighted Average Shares Outstanding | 65.11M | 49.80M | 30.24M | 12.99M | 8.59M | 12.92M | 6.27M |
| Weighted Average Shares Outstanding Diluted | 65.11M | 49.80M | 30.24M | 12.99M | 8.59M | 12.92M | 6.27M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $40.58M | $22.35M | $32.55M | $45.75M | $74.59M | $9.81M | $23.89M |
| Short Term Investments | $- | $80.40M | $65.34M | $- | $- | $- | $- |
| Cash and Short Term Investments | $40.58M | $102.75M | $97.89M | $45.75M | $74.59M | $9.81M | $23.89M |
| Net Receivables | $- | $- | $- | $- | $- | $- | $167.00K |
| Inventory | $- | $- | $- | $- | $- | $- | $1 |
| Other Current Assets | $2.45M | $2.07M | $2.94M | $4.34M | $2.65M | $311.00K | $872.00K |
| Total Current Assets | $43.02M | $104.82M | $100.83M | $47.92M | $75.92M | $10.12M | $24.93M |
| Property Plant Equipment Net | $21.33M | $35.28M | $4.47M | $5.86M | $4.47M | $3.42M | $103.00K |
| Goodwill | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $- | $1.39M | $329.00K | $329.00K | $329.00K | $329.00K |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $1.99M | $2.50M | $3.28M | $762.00K | $118.00K | $1.10M | $- |
| Total Non-Current Assets | $23.32M | $37.78M | $9.14M | $6.95M | $4.91M | $4.84M | $432.00K |
| Other Assets | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $66.35M | $142.60M | $109.97M | $54.87M | $80.83M | $14.96M | $25.36M |
| Account Payables | $1.18M | $3.13M | $2.62M | $3.12M | $922.00K | $1.07M | $631.00K |
| Short Term Debt | $4.12M | $8.91M | $3.51M | $2.15M | $1.97M | $899.00K | $- |
| Tax Payables | $- | $- | $- | $- | $- | $- | $- |
| Deferred Revenue | $398.00K | $1.66M | $1.27M | $9.79M | $2.83M | $3.13M | $- |
| Other Current Liabilities | $6.93M | $9.37M | $9.03M | $3.18M | $1.99M | $3.24M | $1.33M |
| Total Current Liabilities | $12.63M | $19.60M | $14.47M | $18.25M | $4.88M | $5.21M | $1.96M |
| Long Term Debt | $30.26M | $21.45M | $667.00K | $379.00K | $1.45M | $2.43M | $- |
| Deferred Revenue Non-Current | $- | $12.14M | $14.08M | $1.93M | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $-14.08M | $-1.93M | $- | $- | $- |
| Other Non-Current Liabilities | $11.86M | $- | $- | $- | $- | $- | $130.47M |
| Total Non-Current Liabilities | $42.12M | $33.58M | $14.74M | $2.31M | $1.45M | $2.43M | $130.47M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $54.75M | $53.18M | $29.21M | $20.55M | $6.34M | $7.63M | $132.43M |
| Preferred Stock | $- | $- | $- | $- | $80.83M | $130.67M | $130.35M |
| Common Stock | $65.00K | $57.00K | $32.00K | $13.00K | $13.00K | $6.00K | $6.00K |
| Retained Earnings | $-404.79M | $-311.36M | $-248.68M | $-193.40M | $-149.88M | $-127.76M | $-111.45M |
| Accumulated Other Comprehensive Income Loss | $- | $33.00K | $10.00K | $- | $-80.83M | $0 | $-2.80M |
| Other Total Stockholders Equity | $416.32M | $400.69M | $329.39M | $227.70M | $305.19M | $4.42M | $-127.55M |
| Total Stockholders Equity | $11.59M | $89.42M | $80.75M | $34.32M | $74.49M | $7.33M | $-107.07M |
| Total Equity | $11.59M | $89.42M | $80.75M | $34.32M | $74.49M | $7.33M | $-107.07M |
| Total Liabilities and Stockholders Equity | $66.35M | $142.60M | $109.97M | $54.87M | $80.83M | $14.96M | $25.36M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $66.35M | $142.60M | $109.97M | $54.87M | $80.83M | $14.96M | $25.36M |
| Total Investments | $- | $80.40M | $65.34M | $329.00K | $329.00K | $329.00K | $329.00K |
| Total Debt | $34.38M | $26.88M | $2.22M | $1.45M | $2.44M | $3.33M | $- |
| Net Debt | $-6.20M | $4.53M | $-30.33M | $-44.29M | $-72.15M | $-6.48M | $-23.89M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 |
|---|---|---|---|---|---|---|---|
| Net Income | $-93.44M | $-62.68M | $-55.28M | $-43.51M | $-22.13M | $-16.31M | $-6.03M |
| Depreciation and Amortization | $471.00K | $278.00K | $1.07M | $1.00M | $95.00K | $27.00K | $82.00K |
| Deferred Income Tax | $- | $- | $- | $-2.42M | $- | $- | $- |
| Stock Based Compensation | $6.72M | $5.89M | $5.45M | $2.77M | $1.81M | $244.00K | $406.00K |
| Change in Working Capital | $-6.35M | $-4.88M | $4.55M | $13.92M | $-879.00K | $2.11M | $79.00K |
| Accounts Receivables | $- | $- | $- | $- | $- | $- | $164.00K |
| Inventory | $- | $- | $- | $- | $- | $- | $- |
| Accounts Payables | $-1.89M | $450.00K | $-2.41M | $2.35M | $345.00K | $-205.00K | $134.00K |
| Other Working Capital | $-4.46M | $-5.33M | $6.97M | $11.57M | $-1.22M | $2.32M | $-55.00K |
| Other Non Cash Items | $22.58M | $-1.90M | $824.00K | $2.42M | $-45.00K | $167.00K | $-1.18M |
| Net Cash Provided by Operating Activities | $-70.01M | $-63.30M | $-43.38M | $-25.82M | $-21.14M | $-13.75M | $-6.64M |
| Investments in Property Plant and Equipment | $-2.34M | $-1.05M | $-164.00K | $-3.38M | $-1.77M | $-211.00K | $-37.00K |
| Acquisitions Net | $- | $- | $- | $- | $- | $- | $- |
| Purchases of Investments | $-47.95M | $-122.42M | $-64.84M | $- | $- | $- | $- |
| Sales Maturities of Investments | $130.59M | $110.89M | $- | $- | $- | $- | $- |
| Other Investing Activities | $- | $-1 | $-64.84M | $- | $- | $- | $- |
| Net Cash Used for Investing Activities | $80.31M | $-12.58M | $-65.01M | $-3.38M | $-1.77M | $-211.00K | $-37.00K |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $500.00K |
| Common Stock Issued | $8.82M | $69.24M | $100.50M | $604.00K | $59.89M | $111.00K | $12.00K |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $-287.00K | $-3.55M | $-4.24M | $359.00K | $27.81M | $-115.00K | $57.71M |
| Net Cash Used Provided by Financing Activities | $8.53M | $65.69M | $96.26M | $359.00K | $87.70M | $-115.00K | $29.21M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $- | $- | $- |
| Net Change in Cash | $18.82M | $-10.20M | $-12.13M | $-28.85M | $64.78M | $-14.08M | $22.54M |
| Cash at End of Period | $42.57M | $23.75M | $33.94M | $46.08M | $74.92M | $10.14M | $24.22M |
| Cash at Beginning of Period | $23.75M | $33.94M | $46.08M | $74.92M | $10.14M | $24.22M | $1.68M |
| Operating Cash Flow | $-70.01M | $-63.30M | $-43.38M | $-25.82M | $-21.14M | $-13.75M | $-6.64M |
| Capital Expenditure | $-2.34M | $-1.05M | $-164.00K | $-3.38M | $-1.77M | $-211.00K | $-37.00K |
| Free Cash Flow | $-72.35M | $-64.35M | $-43.55M | $-29.20M | $-22.92M | $-13.96M | $-6.68M |